Latest News from: University of Maryland Medical Center

Filters close
Released: 14-Nov-2017 2:00 PM EST
Study: Process Used to Select Lung Transplant Patients May Need to Be Changed
University of Maryland Medical Center

New research from the University of Maryland School of Medicine suggests that the system for choosing transplant recipients in chronic obstructive pulmonary disease (COPD) may underestimate how long a person might survive without a lung transplant and therefore, may mislead clinicians.

Released: 1-Nov-2017 2:45 PM EDT
New Study: Innovative Heart Device Is Safe and Effective
University of Maryland Medical Center

A new study finds that the Harpoon Mitral Valve Repair System, an image-guided device based on technology developed at the University of Maryland School of Medicine, is safe and effective.

Released: 20-Sep-2017 11:50 AM EDT
New Clinical Trial Explores Combining Immunotherapy and Radiation for Newly Diagnosed Sarcoma Patients
University of Maryland Medical Center

University of Maryland School of Medicine researchers are investigating a new approach to treat high-risk soft-tissue sarcomas by combining two immunotherapy drugs with radiation therapy to stimulate the immune system to destroy the main tumor as well as leftover microscopic cancer cells that may seed other tumors.

Released: 11-Sep-2017 9:00 AM EDT
New Study Shows Novel Collaborative Intensive Care Can Significantly Improve Treatment for Heart Patients – and Cut Costs
University of Maryland Medical Center

Researchers at the University of Maryland School of Medicine have found that a new, collaborative treatment model for seriously ill heart patients with breathing difficulties results in better care and lower costs.

Released: 23-Aug-2017 9:00 AM EDT
New Use of Blood Cleaning Device Saves High-Risk Patients with Liver Failure
University of Maryland Medical Center

University of Maryland School of Medicine researchers report that a device that removes toxins from the blood can also effectively provide a bridge to liver transplantation or buy time for a traumatically injured liver to heal, suggesting broader uses for the device than previously thought.

Released: 21-Jul-2017 11:35 AM EDT
Civil Unrest After Freddie Gray’s Death Harms Health in Baltimore Mothers
University of Maryland Medical Center

The April 2015 civil unrest associated with Freddie Gray’s death while in police custody caused a significant spike of stress in mothers of young children living in affected neighborhoods, according to new research from the University of Maryland School of Medicine (UM SOM). The research, conducted before, during and after the period of civil unrest, found that the number of mothers with depressive symptoms increased from an average of 21% before the incident to an average of 31% during the acute period, spiking to 50% in August 2015. Mothers also reported concerns about disruptions in daily routines such as eating, sleeping and shopping, all of which can undermine maternal wellbeing and negatively affect parenting behaviors and subsequently, child development.

   
Released: 5-May-2017 1:05 PM EDT
Secondhand Smoke Ups Heart Disease in Unique Group of Female Nonsmokers – Amish Women
University of Maryland Medical Center

Research at the University of Maryland School of Medicine, conducted in a Pennsylvania Amish community where virtually no women smoke, finds effects of secondhand smoke differ between men and women.

Released: 10-Jan-2017 3:30 PM EST
University of Maryland Medical Center Offers Genetic Testing as Standard of Care to Help Improve Outcomes for Heart Stent Patients
University of Maryland Medical Center

The University of Maryland Medical Center (UMMC) is now offering a simple genetic test to patients who receive heart stents to determine whether they have a genetic deficiency that affects how they respond to a common drug to prevent blood clots. Patients are typically given the medication, clopidogrel, to prevent cardiovascular events after having a stent placed in a coronary artery to treat a blockage.

Released: 20-Dec-2016 2:00 PM EST
First U.S. Babies Treated in Unique Study of Adult Stem Cell Therapy for Congenital Heart Disease
University of Maryland Medical Center

Researchers at the University of Maryland School of Medicine (UM SOM) and the Interdisciplinary Stem Cell Institute (ISCI) at the University of Miami Miller School of Medicine have begun testing to see whether adult stem cells derived from bone marrow benefit children with the congenital heart defect hypoplastic left heart syndrome (HLHS).

Released: 14-Dec-2016 1:30 PM EST
New Study Shows That Lung-Sparing Surgery for Patients with Advanced Mesothelioma Results in Prolonged Survival
University of Maryland Medical Center

Patients with advanced malignant pleural mesothelioma (MPM) treated with a combination of surgery to remove the cancer but save their lung, plus photodynamic therapy and chemotherapy, had a median survival of nearly three years, with a subset of patients living longer than seven years, according to new research published in the Annals of Thoracic Surgery.

4-Oct-2016 5:00 PM EDT
Researchers Identify Novel Mechanism in Combination Drug Therapy for Acute Myeloid Leukemia, Other Cancers
University of Maryland Medical Center

Researchers have discovered a novel mechanism in a combination drug therapy that shows potential as a new approach for treating acute myeloid leukemia (AML) and many other cancers. When combined, these agents cause interactions that significantly disrupt cancer cells’ ability to survive DNA damage, according to a preclinical study published today in the journal Cancer Cell.

Released: 24-Aug-2016 5:30 PM EDT
NEJM Study: MRI-Guided Focused Ultrasound Effective to Treat Essential Tremor, Most Common Movement Disorder
University of Maryland Medical Center

Treatment with MRI-guided focused ultrasound significantly improves tremors and quality of life in patients with essential tremor (ET), the most common movement disorder, according to a study published in the August 25 issue of the New England Journal of Medicine. Researchers at the University of Maryland School of Medicine (UM SOM), were among an international group of investigators studying this new noninvasive treatment, which was recently approved by the U.S. Food and Drug Administration (FDA), based on this research.

18-Jul-2016 3:00 PM EDT
New Surgical Tool for Mitral Valve Repair Demonstrates Success in First Human Clinical Study
University of Maryland Medical Center

Researchers investigating a novel device to repair the mitral valve report 100 percent procedural success in a first-in-humans, safety and performance study. The device, deployed while the heart is beating, avoids open-heart surgery, automates a key part of the valve repair process, simplifies the procedure and reduces operating room time.

Released: 6-Jul-2016 10:25 AM EDT
Researchers Begin Promising Malaria Vaccine Trial in Burkina Faso
University of Maryland Medical Center

Malaria is one of the world’s deadliest diseases: it infects hundreds of millions of people every year, and kills about half a million, most of them under five years of age. There is no vaccine. Now, researchers at the University of Maryland School of Medicine are testing a malaria vaccine that has shown success in early tests.

Released: 27-Jun-2016 8:00 AM EDT
Patient Avoids Dialysis Through Simultaneous Polycystic Kidney Removal and Kidney Transplant During 28-Person Kidney Swap
University of Maryland Medical Center

In a first-of-its-kind procedure in the United States, a patient was able to avoid dialysis when surgeons simultaneously removed two diseased kidneys and also transplanted a kidney from a living donor – all as part of a 28-person paired kidney exchange

Released: 15-Jun-2016 10:00 AM EDT
The Muffin Study: Mono- vs Polyunsaturated Fats in Patients with Metabolic Syndrome
University of Maryland Medical Center

A batch of muffins, made with a special recipe formulated by the U.S. Department of Agriculture, yielded unexpected health benefits in patients with metabolic syndrome during a first-of-its-kind clinical study at the University of Maryland School of Medicine.

Released: 31-May-2016 12:20 PM EDT
University of Maryland Greenebaum Cancer Center Earns National Cancer Institute's Highest Designation
University of Maryland Medical Center

The University of Maryland Marlene and Stewart Greenebaum Cancer Center has been awarded the National Cancer Institute’s highest designation as a Comprehensive Cancer Center. The prestigious distinction recognizes the cancer center’s high caliber of scientific leadership and robust programs in basic, clinical and population science research, placing it in the top tier of cancer centers nationwide. The new name of the center is the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).

10-May-2016 4:00 PM EDT
New Study: Has HDL, the "Good" Cholesterol Been Hyped?
University of Maryland Medical Center

A new study shows for the first time that HDL’s heart disease protection depends on the levels of two other blood fats or lipids associated with heart disease. If these fats are not within normal ranges, even a high HDL may not be protective.

Released: 31-Mar-2016 9:05 AM EDT
New Recommendations Link Better Sleep to Improved Concussion Outcomes
University of Maryland Medical Center

A panel of sleep and brain injury specialists recommends specific steps to test and develop sleep-related treatments to improve the outcome of mild traumatic brain injury. The recommendations appear online ahead of print in the journal Neurotherapeutics.

23-Feb-2016 11:00 AM EST
Shock Trauma Model for Critically Ill Patients Cuts Transfer Time in Half, Expediting Access to Lifesaving Diagnostics and Specialty Care When Minutes Count
University of Maryland Medical Center

A novel unit to care for critically ill patients significantly speeds access to specialized care, according to a new study by physician scientists at the University of Maryland School of Medicine and the University of Maryland Medical Center.

Released: 15-Oct-2015 12:00 PM EDT
Researchers to Begin Clinical Trial of GammaPod, a First-of-Its-Kind Radiation Therapy System to Treat Early Breast Cancers
University of Maryland Medical Center

After more than a decade of research and development, researchers in the Department of Radiation Oncology at the University of Maryland School of Medicine will begin enrolling patients in the first clinical trial of GammaPod,™ a new high-precision, image-guided radiation therapy system specifically designed to treat early-stage breast cancer.

Released: 1-Sep-2015 9:00 AM EDT
University of Maryland Medicine Tests Novel Treatment for Parkinson’s
University of Maryland Medical Center

University of Maryland Medicine and its Center for Metabolic Imaging and Image-Guided Therapeutics has begun to use MRI-guided focused ultrasound on a deep structure within the brain related to Parkinson’s disease – the globus pallidus.

Released: 18-Aug-2015 3:00 PM EDT
Use of Contact Precautions to Prevent Spread of MRSA and VRE in Hospitalized Patients Should Be Customized Based on Local Needs and Resources
University of Maryland Medical Center

A group of epidemiologists and infection prevention specialists led by Daniel Morgan, MD, MS, an associate professor of Epidemiology & Public Health at the University of Maryland School of Medicine, reviewed current practice and existing literature on the use of contact precautions for MRSA and VRE to build a framework for decision-making based on all available evidence.

17-Jul-2015 4:30 PM EDT
Patients' Own Genetically Altered Immune Cells Show Promise in Fighting Blood Cancer
University of Maryland Medical Center

In recent years, immunotherapy has emerged as a promising treatment for certain cancers. Now this strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable. The results appeared in a study published online today in Nature Medicine.

Released: 13-Jul-2015 12:10 PM EDT
Scientists Identify New Compounds That May Treat Depression Rapidly With Few Side Effects
University of Maryland Medical Center

A new study has identified promising compounds that could successfully treat depression in less than 24 hours while minimizing side effects. The compounds could offer significant advantages over current antidepressant medications.

Released: 29-Jun-2015 3:20 PM EDT
First-Ever Possible Treatments For MERS; Researchers Identify Two Promising Candidates
University of Maryland Medical Center

As the South Korean MERS outbreak continues, researchers have discovered and validated two therapeutics that show early promise in preventing and treating the disease, which can cause severe respiratory symptoms, and has a death rate of 40 percent.

Released: 29-Jun-2015 11:30 AM EDT
Scientists Identify “Decoy” Molecule That Could Help Sharply Reduce Risk of Flu Death
University of Maryland Medical Center

The flu virus can be lethal. But what is often just as dangerous is the body’s own reaction to the invader. Now, a University of Maryland School of Medicine researcher has identified a “decoy” molecule that can rein in this runaway inflammatory response.

Released: 22-May-2015 2:05 PM EDT
New Research Leads to FDA Approval of First Drug to Treat Radiation Sickness
University of Maryland Medical Center

New research has led to FDA approval of the use of a drug to treat the effects of radiation exposure following a nuclear incident. The drug, Neupogen, is the first ever approved for the treatment of acute radiation injury.

Released: 24-Apr-2015 3:55 PM EDT
Researchers Discover Never-Before-Seen Tick-Borne Disease
University of Maryland Medical Center

Tick-borne diseases are a major public health problem around the world. Now, just in time for spring and the explosion of ticks in forests, lawns and trails, a new study by researchers from China and the University of Maryland School of Medicine has uncovered a never-before-seen illness transmitted by ticks. It’s possible that the disease could be a “substantial health threat” to humans and animals in areas where the carrier tick is common, the authors say.

Released: 22-Apr-2015 3:55 PM EDT
Five Years After Gulf Spill, Residents Still Suffering Significant Mental Health Problems
University of Maryland Medical Center

Five years ago the BP Deepwater Horizon oil platform exploded. The spill caused enormous environmental damage, but it also caused great stress among Gulf Coast residents. Even now, a significant percentage of people there continue to deal with anxiety, depression and other mental health issues, researchers say.

Released: 21-Apr-2015 9:55 AM EDT
New Study Unravels Why Common Blood Pressure Medicine Can Fail
University of Maryland Medical Center

Every year, more than 120 million prescriptions are written worldwide for thiazide drugs, a group of salt-lowering medicines used to treat high blood pressure. These drugs are often very effective. But in some patients, they don't work. The reasons for this have remained a mystery. Now, a new study by researchers at the University of Maryland School of Medicine (UM SOM) has revealed a key mechanism for this failure.

20-Apr-2015 11:00 AM EDT
New Guideline Authored by University of Maryland Neurologist Advises When to Treat a First Seizure
University of Maryland Medical Center

A new guideline authored by Allan Krumholz, MD, a professor of neurology at the University of Maryland School of Medicine, found that administering an antiepileptic medication immediately after a first seizure reduces the risk of having another seizure within two years.

Released: 16-Apr-2015 11:40 AM EDT
New Research Sheds Light on How Popular Probiotic Benefits The Gut
University of Maryland Medical Center

The gut bacteria Lactobacillus rhamnosus GG has a reputation as a helpful microbe. Now, researchers at the University of Maryland School of Medicine have come up with an explanation for why. It appears that the bacteria may boost the activity of other gut microbes.

Released: 1-Apr-2015 5:15 PM EDT
University Of Maryland School Of Medicine Plans To Launch Major New Global Health And Vaccine Institute; Building On Longstanding Worldwide Leadership In Malaria Research And Vaccine Development
University of Maryland Medical Center

University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA, announced today that the School of Medicine (UM SOM) plans to establish a major new Institute for Global Health (IGH), bringing together decades of UM SOM research, treatment and vaccine development around the world, and expanding the School’s platform as the premier, leading center for global health research, treatment and prevention. The new Institute will focus on vaccine development and malaria research, and will house the UM SOM’s reconfigured Center for Vaccine Development (CVD) as well as a newly-formed Center for Malaria Research (CMR).

Released: 31-Mar-2015 10:05 AM EDT
Researchers Unravel Mechanism That Plays Key Role In Sexual Differentiation of Brain
University of Maryland Medical Center

During prenatal development, the brains of most animals, including humans, develop specifically male or female characteristics. But scientists have known little about the details of how this differentiation occurs. Now, a new study by researchers at the University of Maryland School of Medicine has illuminated details about this process.

4-Mar-2015 9:00 AM EST
University of Maryland Medical Center Teams Up With Carroll Hospital Center on Tele-Stroke Program
University of Maryland Medical Center

Carroll Hospital Center physicians will now have 24/7 remote access to the University of Maryland Medical Center’s Brain Attack Team through a new telemedicine service for stroke patients, the hospitals announced today.

Released: 6-Feb-2015 8:00 AM EST
University of Maryland Medicine Announces New National Program in Lung Healing to Develop Innovative Approaches for Preventing and Treating Acute Lung Disease
University of Maryland Medical Center

University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, and Jeffrey A. Rivest, MS, President and Chief Executive Officer of University of Maryland Medical Center (UMMC), today announced the official launch of a new “Program in Lung Healing,” that will further the School’s position as a national leader in research, education and clinical innovation for acute ailments of the lung and respiratory system.

22-Jan-2015 5:00 PM EST
Targeted MRI/Ultrasound Beats Standard Biopsy to Detect High-Risk Prostate Cancer
University of Maryland Medical Center

Targeted biopsy using new fusion technology that combines magnetic resonance imaging (MRI) with ultrasound is more effective than standard biopsy in detecting high-risk prostate cancer, according to a large-scale study published today in JAMA.

Released: 21-Nov-2014 1:00 PM EST
Investigational Drug Reduces High Potassium Levels in Chronic Kidney Disease Patients
University of Maryland Medical Center

Research published today found that the investigational drug patiromer decreased high potassium levels and maintained normal potassium levels in patients with chronic kidney disease. The results of a multicenter trial appear in the New England Journal of Medicine.

Released: 2-Oct-2014 5:15 PM EDT
Researchers Identify New Pathway Linking the Brain to High Blood Pressure
University of Maryland Medical Center

New research by scientists at the University of Maryland School of Medicine (UM SOM) and the Ottawa Heart Institute has uncovered a new pathway by which the brain uses an unusual steroid to control blood pressure.

Released: 29-Sep-2014 12:30 PM EDT
Institute of Human Virology (IHV) Welcomes Renowned Infectious Disease Specialist Dr. Shyamasundaran Kottilil
University of Maryland Medical Center

Shyamasundaran Kottilil, MBBS, PhD, a world-renowned expert in infectious disease, has joined the faculty of the University of Maryland School of Medicine’s Institute of Human Virology as Co-Director of IHV’s Clinical Research Unit and Associate Director for Clinical Research.

Released: 28-Aug-2014 3:50 PM EDT
University of Maryland School of Medicine’s Center for Vaccine Development Leading the Way in Testing of Potential Ebola Vaccine as Part of Unprecedented International Consortium
University of Maryland Medical Center

The Center for Vaccine Development at the University of Maryland School of Medicine is leading an internationally-acclaimed consortium of scientists in an unprecedented multi-trial collaboration to test a potential vaccine that could help prevent the continuing spread of the deadly Ebola virus.

Released: 5-May-2014 4:00 PM EDT
Key Political and Healthcare Officials Discuss the Impact of the Affordable Care Act and Its Impact on the Poor and Underserved
University of Maryland Medical Center

Today, the University of Maryland School of Medicine presented an update on the national implementation of the Affordable Care Act (ACA), focusing on the impact to poor and underserved communities and individuals. Congressman Elijah Cummings was the featured speaker for the event.

Released: 2-May-2014 4:05 PM EDT
Former First Lady Eleanor Roosevelt’s Cause of Death and End of Life Issues Examined During 21st Annual Historical Clinicopathological Conference
University of Maryland Medical Center

The Medical Alumni Association of the University of Maryland School of Medicine (SOM) along with notable national experts review the cause and end of life issues surrounding the death of one of the most prominent figures of the 20th Century: former First Lady and leading women’s and civil rights advocate Eleanor Roosevelt as part of the 21st Annual Historical Clinicopathological Conference.

2-Jan-2014 1:00 PM EST
Two-Sizes-Too-Small ‘Grinch’ Effect Hampers Heart Transplantation Success
University of Maryland Medical Center

Current protocols for matching donor hearts to recipients foster sex mismatching and heart size disparities, according to a first-of-its kind analysis by physicians at the University of Maryland School of Medicine. Matching by donor heart size may provide better outcomes for recipients.


Showing results 101–150 of 299


close
0.65561